(1)
MURUGAPPAN M; BABU B; SHANKAR V; YUSUF M; JAWAHAR N. ROLE OF FDA 483 OBSERVATIONS IN QUALITY MANAGEMENT SYSTEMS: ENHANCING COMPLIANCE AND RISK MANAGEMENT. Asian J Pharm Clin Res 2025, 18, 44-51.